We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$15.1B
AUM Growth
+$367M
Cap. Flow
-$1.2B
Cap. Flow %
-7.98%
Top 10 Hldgs %
15.48%
Holding
700
New
227
Increased
111
Reduced
135
Closed
190

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$220M
2
EL icon
Estee Lauder
EL
+$166M
3
ADSK icon
Autodesk
ADSK
+$153M
4
TXN icon
Texas Instruments
TXN
+$140M
5
DELL icon
Dell
DELL
+$134M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Consumer Discretionary 14.27%
3 Healthcare 14.13%
4 Industrials 12.15%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
351
Gossamer Bio
GOSS
$86.1M
$2.66M 0.02%
2,913,216
-3,890,284
-57% -$2.87M
AMP icon
352
Ameriprise Financial
AMP
$49.2B
$2.64M 0.02%
6,962
+2,888
+71% +$990K
SGMT icon
353
Sagimet Biosciences
SGMT
$591M
$2.64M 0.02%
486,560
+246,531
+103% +$1.16M
IMVT icon
354
Immunovant
IMVT
$8.24B
$2.6M 0.02%
+61,820
New +$2.27M
ADI icon
355
Analog Devices
ADI
$187B
$2.58M 0.02%
12,978
-995,392
-99% -$178M
GDS icon
356
GDS Holdings
GDS
$6.29B
$2.52M 0.02%
276,275
-342,230
-55% -$3.46M
AESI icon
357
Atlas Energy Solutions
AESI
$1.47B
$2.49M 0.02%
144,612
-35,980
-20% -$662K
UBX
358
CALL
DELISTED
Unity Biotechnology
UBX
$2.48M 0.02%
1,286,000
CLS icon
359
Celestica
CLS
$36.2B
$2.43M 0.02%
+83,039
New +$2.21M
HIPO icon
360
CALL
Hippo Holdings
HIPO
$856M
$2.37M 0.02%
+260,000
New +$2.16M
SRZN icon
361
CALL
Surrozen
SRZN
$295M
$2.35M 0.02%
+250,000
New +$1.74M
HELP
362
Cybin Inc
HELP
$620M
$2.33M 0.02%
+149,558
New +$2.78M
TMCI icon
363
Treace Medical Concepts
TMCI
$303M
$2.32M 0.02%
182,112
+32,746
+22% +$331K
MGTX icon
364
MeiraGTx Holdings
MGTX
$1.21B
$2.32M 0.02%
330,182
IMTX icon
365
CALL
Immatics
IMTX
$1.33B
$2.27M 0.02%
215,223
WAB icon
366
Wabtec
WAB
$49.7B
$2.2M 0.01%
17,323
-294,462
-94% -$33.2M
JANX icon
367
Janux Therapeutics
JANX
$1B
$2.12M 0.01%
197,490
+22,490
+13% +$194K
UBX
368
DELISTED
Unity Biotechnology
UBX
$2.01M 0.01%
1,041,331
+1,002,636
+2,591% +$1.86M
NKTR icon
369
Nektar Therapeutics
NKTR
$2.53B
$1.99M 0.01%
234,618
+145,837
+164% +$1.1M
GDYN icon
370
Grid Dynamics Holdings
GDYN
$621M
$1.96M 0.01%
+146,985
New +$1.79M
CARR icon
371
Carrier Global
CARR
$52.3B
$1.95M 0.01%
+34,014
New +$1.8M
CMAX
372
CALL
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.95M 0.01%
+4,339
New +$180K
SYK icon
373
Stryker
SYK
$133B
$1.94M 0.01%
+6,489
New +$1.82M
ELUT icon
374
CALL
Elutia
ELUT
$36M
$1.93M 0.01%
+893,445
New +$1.46M
ALGS icon
375
Aligos Therapeutics
ALGS
$47.8M
$1.91M 0.01%
+115,289
New +$1.98M

Similar funds

Alyeska Investment Group's Q4 2023 Portfolio in Review

As of Q4 2023, Alyeska Investment Group held 700 positions worth $15.1B, up 2.5% from $14.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $1.2B in Q4 2023, closing 190 positions and reducing 135 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in Estee Lauder worth $183M.

  • Alyeska Investment Group's largest Q4 2023 buy was Estee Lauder: 1,254,443 shares worth $183M.
  • Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2023, an estimated $220M increase.
  • Alyeska Investment Group's biggest Q4 2023 reduction was Boeing, cutting an estimated $192M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q4 2023, selling an estimated $187M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $15.1B portfolio in Q4 2023.
  • Alyeska Investment Group opened 227 new positions and closed 190 in Q4 2023.
  • Alyeska Investment Group's portfolio value rose 2.5% quarter-over-quarter to $15.1B.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.